Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

RNA-transfected dendritic cells.

Smita Nair1, David Boczkowski

  • 1Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA. s.nair@cgct.duke.edu

Expert Review of Vaccines
|August 7, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Respiratory function profiling using non-invasive methods in children aged 7-18 years: a hospital based study from North India.

BMC pediatrics·2026
Same author

Negative cooperativity drives activity of capsid-directed antivirals against hepatitis B virus.

Science advances·2026
Same author

Novel mutations and gene duplication detected in diamide-resistant field populations of rice leaf folder, Cnaphalocrocis medinalis.

Insect biochemistry and molecular biology·2026
Same author

DNA synthesis inside the hepatitis B virus creates a high-energy spool.

bioRxiv : the preprint server for biology·2026
Same author

First Report on Field-Evolved Resistance to Lambda-Cyhalothrin in Rice Leaf Folder (Cnaphalocrocis medinalis Guenee) Populations in Kerala, India: Implications and Concerns of Its Environmental Impact.

Environmental toxicology·2026
Same author

Unravelling the complex bacterial diversity in the rice rhizosphere of Kole lands of Thrissur through the metagenomics approach.

3 Biotech·2025
Same journal

Projected health and economic impact of PCV20 vaccination in UK children: a dynamic transmission model.

Expert review of vaccines·2026
Same journal

Evaluating the societal value of adult respiratory vaccination in Sweden: a benefit-cost analysis.

Expert review of vaccines·2026
Same journal

Evaluating the socioeconomic value of adult respiratory immunization in Spain: a benefit-cost analysis.

Expert review of vaccines·2026
Same journal

Whole cell and acellular pertussis vaccines - rethinking the evidence.

Expert review of vaccines·2026
Same journal

Modeling the potential public health and economic impact and cost-effectiveness of vaccination strategies using an adapted COVID-19 vaccine in the Dominican Republic.

Expert review of vaccines·2026
Same journal

Narrative shielding and prebunking: a synergistic strategy against vaccine hesitancy in pediatrics.

Expert review of vaccines·2026
See all related articles

Dendritic cells are potent antigen-presenting cells. This study explores using RNA-pulsed dendritic cells for vaccines, reviewing their use in stimulating immune responses against diseases.

Area of Science:

  • Immunology
  • Vaccinology

Background:

  • Dendritic cells are highly effective antigen-presenting cells due to their antigen uptake, processing capabilities, and expression of MHC and costimulatory molecules.
  • These properties make them ideal for priming naive T-cells, leading to their investigation in vaccine development.

Purpose of the Study:

  • To explore the use of RNA as an antigen source for dendritic cell-based vaccines.
  • To review current research on RNA-pulsed dendritic cells in both murine and human models.

Main Methods:

  • Focus on utilizing RNA to load dendritic cells with antigen.
  • Review of studies employing RNA-pulsed dendritic cells for vaccine strategies.

Main Results:

  • RNA offers a versatile method for antigen delivery to dendritic cells.

Related Experiment Videos

  • Studies in murine and human settings demonstrate the potential of RNA-pulsed dendritic cell vaccines.
  • Conclusions:

    • RNA-pulsed dendritic cells represent a promising approach for developing vaccines against tumors and infectious diseases.
    • Further research into RNA-based antigen delivery can enhance vaccine efficacy.